slides · global inventory
Analyze Data
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 58,039
Current window 30,901-30,930
Pages 1,935
Rows per page 30
Slide function
30,901-30,930 of 58,039
13
The slide includes a footnote defining the response rate criteria and a disclaimer that it is not for promotion.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
14
The chart highlights a 74.1% mean reduction in NRS score for MYFEMBREE vs 26.4% for placebo at week 24.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
15
The slide highlights a 49.7% reduction in NMPP NRS score at week 24 for the pooled MYFEMBREE group compared to 36.0% for placebo.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
16
The chart highlights a 57.9% mean reduction in pain domain score for the pooled MYFEMBREE group versus 32.6% for placebo at week 24.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
17
The chart shows a greater reduction in pain scores for the treatment group compared to placebo, with p < 0.05 significance indicated for both trials.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Before After1 hit
18
Includes clinical trial data for opioid rescue usage at baseline vs month 6.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
20
Clinical safety data table for MYFEMBREE.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
21
Data from SPIRIT 1 and 2 studies only.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
22
The chart shows a decrease in BMD for the treatment group compared to a slight increase for the placebo group.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
23
The slide compares a control/observational group against a treatment group (SPIRIT study) to show BMD changes.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
24
The table presents efficacy percentages for MYFEMBREE vs placebo (in parentheses) for three pain metrics, plus safety data.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Beat · Solution1 hit
29
The slide uses a donut chart to visualize the split between initial coverage and ongoing payer discussions.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Beat · Market Size1 hit
06
Nexters | Results Presentation Deck | 13 slidesNexters | Results Presentation Deck | 13 slides · Nexters
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
07
The slide uses bar charts to show year-over-year growth metrics for Nexters.Nexters | Results Presentation Deck | 13 slides · Nexters
Conference presentation Investor relations Beat · Evidence1 hit
08
The slide uses stacked bar charts to show composition and YoY growth annotations.Nexters | Results Presentation Deck | 13 slides · Nexters
Conference presentation Investor relations Beat · Evidence1 hit
11
Financial data presented in thousands of currency units.Nexters | Results Presentation Deck | 13 slides · Nexters
Conference presentation Investor relations Beat · Development1 hit
12
The slide presents a standard financial P&L table with two columns for quarterly comparison.Nexters | Results Presentation Deck | 13 slides · Nexters
Conference presentation Investor relations Beat · Development1 hit
13
Standard financial reporting table.Nexters | Results Presentation Deck | 13 slides · Nexters
Conference presentation Investor relations Beat · Development1 hit
05
Includes specific pilot partner performance data in a table.Nikola | Results Presentation Deck | 22 slides · Nikola
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
11
The table displays financial performance metrics including revenue, cost of revenues, operating expenses, and net loss per share.Nikola | Results Presentation Deck | 22 slides · Nikola
Conference presentation Investor relations Beat · Satisfaction1 hit
12
The table provides a bridge between GAAP and non-GAAP financial metrics.Nikola | Results Presentation Deck | 22 slides · Nikola
Conference presentation Investor relations Beat · Satisfaction1 hit
13
The slide explains the shift of inbound freight and inventory write-downs from R&D to Cost of Revenues.Nikola | Results Presentation Deck | 22 slides · Nikola
Conference presentation Investor relations Beat · Satisfaction1 hit
14
Includes a footnote regarding reconciliation to non-GAAP measures.Nikola | Results Presentation Deck | 22 slides · Nikola
Conference presentation Investor relations Beat · Satisfaction1 hit
15
Data is in thousands except for headcount.Nikola | Results Presentation Deck | 22 slides · Nikola
Conference presentation Investor relations Beat · Satisfaction1 hit
19
The table includes a duplicate column for Q2 2021, likely a typo in the original source document.Nikola | Results Presentation Deck | 22 slides · Nikola
Conference presentation Investor relations Beat · Action1 hit
20
The slide uses a logical flow of arithmetic operations (subtraction, multiplication, addition) to define the business model economics.Oak Street Health | Investor Presentation Deck | 25 slides · Oak St. Health
Pitch deck Investor relations 1 hit
21
The chart uses a stacked bar approach to visualize the contribution of new centers (Year 0-2) vs mature centers (Year 3+).Oak Street Health | Investor Presentation Deck | 25 slides · Oak St. Health
Pitch deck Investor relations 1 hit
23
Includes footnote regarding definition of Gross profit.Oak Street Health | Investor Presentation Deck | 25 slides · Oak St. Health
Pitch deck Investor relations 1 hit
24
The slide provides a breakdown of non-GAAP financial metrics, specifically reconciling net loss to Adjusted EBITDA and calculating contribution margins.Oak Street Health | Investor Presentation Deck | 25 slides · Oak St. Health
Pitch deck Investor relations 1 hit
25
Values in millions, except for patient counts.Oak Street Health | Investor Presentation Deck | 25 slides · Oak St. Health
Pitch deck Investor relations 1 hit